Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioAxis Research
Oss, Netherlands
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
BioAxis Research enables rapid hit-to-lead and lead optimization for drug discovery using advanced computational and cheminformatic tools. The company supports early-stage research and optimization, but is not directly running clinical-stage programs for its own drugs.
- Modalities
- Small moleculeBiologicmRNA-based drugsAntibody
- Industry
- Drug Discovery Services
02
Partnerships
3D-e-Chem consortium (CMBI/Radboudumc, Netherlands eScience Center, Vrije Universiteit Amsterdam)European pharma and screening centersUK charitiesMKB Innovatiestimulering topsectoren Zuid-Nederland (Stimulus funding)
Beyond the preview
Go deeper on BioAxis Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioAxis Research.